These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 6435610
1. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide. Diezel W, Waschke SR, Forner K. Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610 [No Abstract] [Full Text] [Related]
2. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide. Rentz E, Diezel W, Ehrlich A, Forner K. Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122 [Abstract] [Full Text] [Related]
3. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. Verhaegen H, De Cock W, De Cree J, Goldstein G. J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790 [Abstract] [Full Text] [Related]
4. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study. Auteri A, Laghi Pasini F, Pasqui AL, Bilenchi R, Di Perri T. Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):308-11. PubMed ID: 7018514 [No Abstract] [Full Text] [Related]
5. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients. Munno I, Pellegrino NM, Fumo G, Barbieri G, Polimeno G, de Filippis V, Jirillo E. Cytobios; 1987 Feb 29; 52(210-211):167-73. PubMed ID: 3123147 [Abstract] [Full Text] [Related]
6. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study. Auteri A, Laghi Pasini F, Pasqui AL, Bilenchi R, Di Perri T. Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):312-5. PubMed ID: 7018515 [No Abstract] [Full Text] [Related]
7. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide. Laghi Pasini F, Auteri A, Ceccatelli L, Di Perri T. Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):316-22. PubMed ID: 7018516 [Abstract] [Full Text] [Related]
8. Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by N alpha-desacetylthymosin alpha 1. Svedersky LP, Hui A, May L, McKay P, Stebbing N. Eur J Immunol; 1982 Mar 29; 12(3):244-7. PubMed ID: 6284520 [Abstract] [Full Text] [Related]
10. Structural requirements for the biological activity of thymopentin analogs. Heavner GA, Audhya T, Kroon D, Goldstein G. Arch Biochem Biophys; 1985 Oct 29; 242(1):248-55. PubMed ID: 2996431 [Abstract] [Full Text] [Related]
11. Stimulation by thymopoietin oligopeptides of lectin-dependent cell-mediated cytotoxicity in patients with systemic lupus erythematosus. Perl A, Gonzalez-Cabello R, Nékám K, Gergely P, Fehér J. J Clin Lab Immunol; 1985 Nov 29; 18(3):119-22. PubMed ID: 3910838 [Abstract] [Full Text] [Related]
12. Immunokinetics of a single dose of thymopoietin pentapeptide. Di Perri T, Laghi Pasini F, Auteri A. J Immunopharmacol; 1980 Nov 29; 2(4):567-72. PubMed ID: 7009760 [Abstract] [Full Text] [Related]
13. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor. Ochoa EL, Medrano S, de Carlin MC, Dilonardo AM. Cell Mol Neurobiol; 1988 Sep 29; 8(3):325-31. PubMed ID: 3066488 [Abstract] [Full Text] [Related]
14. [Effects of thymopentin and recombinant interferon alpha 2A on the biochemiluminescence of neutrophil granulocytes in subjects with HIV infections]. Latorre A, Romagno D, Palumbo A, Dammacco F. G Clin Med; 1987 Sep 29; 68(6-7):351-5. PubMed ID: 3308608 [No Abstract] [Full Text] [Related]
15. Biologically active analogs of thymopentin with enhanced enzymatic stability. Heavner GA, Kroon DJ, Audhya T, Goldstein G. Peptides; 1986 Sep 29; 7(6):1015-9. PubMed ID: 3031628 [Abstract] [Full Text] [Related]
16. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets. Cooper KD, Kang K, Hanifin JM. Diagn Immunol; 1983 Sep 29; 1(3):211-5. PubMed ID: 6388971 [Abstract] [Full Text] [Related]
17. Modulation of immune response in aged humans through different administration modes of thymopentin. Duchateau J, Servais G, Vreyens R, Delespesse G, Bolla K. Surv Immunol Res; 1985 Sep 29; 4 Suppl 1():94-101. PubMed ID: 3898299 [Abstract] [Full Text] [Related]
18. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization]. Belokrylov GA, Molchanova IV, Popova OIa. Biull Eksp Biol Med; 1989 Nov 29; 108(11):584-7. PubMed ID: 2699257 [Abstract] [Full Text] [Related]
19. Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice. Goldberg EH, Goldstein G, Boyse EA, Scheid MP. Immunogenetics; 1981 Nov 29; 13(3):201-4. PubMed ID: 7024116 [Abstract] [Full Text] [Related]
20. [Treatment of recurrent herpes simplex with thymopoietin-pentapeptide]. Djawari D, Bolla K, Haneke E. Dtsch Med Wochenschr; 1984 Mar 30; 109(13):496-8. PubMed ID: 6368167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]